Medical Escorts Inc Philadelphia, PA - 19115

Medical Escorts Inc is categorized under Blood Related Health Services in Philadelphia, PA and active since 2010.

Medical Escorts Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6219100 by the NAICS.

If you are seeking more information, feel free to contact Zurab Gameashidze, Owner at the company’s single location by writing to 220 Geiger Road # 204, Philadelphia, Pennsylvania PA 19115 or by phoning (215) 677-2000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medical Escorts Inc
Contact Person: Zurab Gameashidze, Owner
Address: 220 Geiger Road # 204, Philadelphia, Pennsylvania 19115
Phone Number: (215) 677-2000
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Blood Related Health Services
SIC Code: 8099
NAICS Code: 6219100
Share This Business:

Medical Escorts Inc was started in 2010 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6219100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Zurab Gameashidze, Owner for inquiries that concern Medical Escorts Inc by calling the company number (215) 677-2000, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Escorts Inc can be found at the coordinates 40.11015,-75.05049 as well as the street address 220 Geiger Road # 204 in Philadelphia, Pennsylvania 19115.

For its online presence, you may visit Medical Escorts Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.